Trillium Granted 180-Day Extension by NASDAQ to Regain Compliance With Minimum Bid Price Rule

NEXT STORY
Stemline Therapeutics Announces ELZONRIS® Clinical Data Selected for Oral Presentation at the 81st Annual Meeting of the Japanese Society of Hematology
PREV STORY
Oncology Pharma Elects Dr. Stefan Gruenwald (MD, PhD) to its Board of Directors
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Novan to Present at the H.C. Wainwright Global Life Sciences Conference

author_avatar
NASDAQ Market News

$112.62 Billion Precision Medicine Market Analysis & Trends 2016 – Therapeutics & Applications Forecasts to 2025

Dublin, Jan. 19, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition ...

author_avatar
NASDAQ Market News

New Roche data for Evrysdi show improved motor function in pre-symptomatic babies after one year and confirm safety profile in previously treated people with spinal muscular atrophy (SMA)

author_avatar
NASDAQ Market News